Von Willebrand disease and angiodysplasia responding to atorvastatin

British Journal of Haematology

Volumn 142, Issue 2, 2008, Pages 308-309

  Sohal, Mamta ^a   Laffan, Mike ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Angiodysplasia; Atorvastatin; Haemorrhage; Von Willebrand disease

Indexed keywords

ANTIGEN; ATORVASTATIN; BLOOD CLOTTING FACTOR 8; CHOLESTEROL; COLLAGEN BINDING PROTEIN; HEMOGLOBIN; IRON; OCTREOTIDE; RISTOCETIN; THALIDOMIDE; TRANEXAMIC ACID; VASCULOTROPIN; VON WILLEBRAND FACTOR; WILFACTIN;

ABDOMINAL ANGIOGRAPHY; ADULT; ANAMNESIS; ANGIODYSPLASIA; ANTIANGIOGENIC ACTIVITY; ARGON PLASMA COAGULATION; BLOOD TRANSFUSION; BRADYCARDIA; CAPSULE ENDOSCOPY; CASE REPORT; CLINICAL FEATURE; COLON MALFORMATION; COLONOSCOPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; HEMOPHILIA A; HUMAN; LABORATORY TEST; LETTER; MALE; MELENA; PRIORITY JOURNAL; SIGMOID; SMALL INTESTINE HEMORRHAGE; STEATORRHEA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VON WILLEBRAND DISEASE;

ANGIODYSPLASIA; ANTICHOLESTEREMIC AGENTS; HEMOPHILIA A; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; TREATMENT OUTCOME; VON WILLEBRAND DISEASES;

EID: 47249093737     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07005.x     Document Type: Letter

References (9)

1. Anderson, M.R. Aaseby, J. (1996) Somatostatin in the treatment of gastrointestinal bleeding caused by angiodyspalsia. Scandinavian Journal of Gastroenterology, 31, 1037 1039.
2. Bauditz, J., Schachschal, G., Wedel, S. Lochs, H. (2004) Thalidomide for treatment of severe intestinal bleeding. Gut, 53, 609 612.
3. Bowers, M., Mcnulty, O. Mayne, E. (2000) Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. British Journal of Haematology, 108, 524 527.
4. Fressinaud, E. Meyer, D. (1993) International survey of patients with von Willebrand disease and angiodysplasia. Thrombosis and haemostasis, 70, 546.
5. Hirr, H.M., Green, P.J. Lindsay, J. (2006) von Willebrand disease and angiodysplasia treated with thalidomide. Haemophilia, 12, 285 286.
6. Junquera, F., Saperas, E., de Torres, I., Vidal, M.T. Malagelada, J. (1999) Increased expression of angiogenic factors in human colonic angiodysplasia. American Journal of Gastroenterology, 94, 1070 1076.
7. Li, M. Losardo, D.W. (2007) Statins and the endothelium. Vascular pharmacology, 46, 1 9.
8. Quick, A.J. (1967) Telangiectasia its relationship to the Minot von Willebrand syndrome. American Journal of the Medical Sciences, 25, 585 601.
9. Skaletz-Rorowski, A., Kureishi, Y., Shiojma, I. Walsh, K. (2004) The pro and antiangiogenic effects of statins. Seminars in Vascular Medicine, 4, 395 400.